(CRSP) Crispr Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Crispr Therapeutics | (CRSP) share price targets
Complete technical analysis of Crispr Therapeutics (CRSP) by charts plus indicators, forecast predictions and share price targets for Crispr Therapeutics (CRSP)
Crispr Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-18 View latest technical analysis
10 day averaged volume of Crispr Therapeutics is 2174370
Date | Daily Closing Price | Open | High | Low | Volume |
18 Mon Nov 2024 | 47.30 | 47.83 | 48.28 | 46.71 | 0.939 times |
15 Fri Nov 2024 | 47.25 | 47.61 | 48.44 | 46.30 | 1.441 times |
14 Thu Nov 2024 | 46.85 | 49.85 | 50.10 | 46.84 | 0.9 times |
13 Wed Nov 2024 | 49.79 | 50.90 | 52.43 | 49.41 | 0.857 times |
12 Tue Nov 2024 | 50.73 | 53.80 | 53.99 | 50.53 | 1 times |
11 Mon Nov 2024 | 54.86 | 53.13 | 59.07 | 53.00 | 1.683 times |
08 Fri Nov 2024 | 51.62 | 51.21 | 52.52 | 50.60 | 0.601 times |
07 Thu Nov 2024 | 51.88 | 51.40 | 53.26 | 51.15 | 0.735 times |
06 Wed Nov 2024 | 50.72 | 51.80 | 51.88 | 49.39 | 1.047 times |
05 Tue Nov 2024 | 50.36 | 49.35 | 50.42 | 47.04 | 0.999 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 47.1 as stoploss in an intra day buy trade for a target of 49.25. However, stock will show a bearish move below 47.1.
Share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Target | 43.42 |
Downside Target | 44.44 |
Upside Target | 48.28 |
Upside Target | 50.50 |
Upside Target | 50.85 |
Upside Target | 51.99 |
Upside Target | 52.31 |
Upside Target | 53.26 |
Upside Target | 57.68 |
Upside Target | 59.07 |
Upside Target | 63.68 |
Intraday share price targets for Crispr Therapeutics (CRSP)
Target Type | Value |
Downside Intraday Target | 46.58 |
Downside Intraday Target | 45.86 |
Upside Intraday Target | 48.15 |
Upside Intraday Target | 49 |
Upside Intraday Target | 47.43 |
Weekly technical analysis of Crispr Therapeutics (CRSP)
Date | Weekly Closing Price | Open | High | Low | Volume |
18 Mon Nov 2024 | 47.30 | 47.83 | 48.28 | 46.71 | 0.16 times |
15 Fri Nov 2024 | 47.25 | 53.13 | 59.07 | 46.30 | 1.428 times |
08 Fri Nov 2024 | 51.62 | 50.44 | 53.26 | 47.04 | 1.178 times |
01 Fri Nov 2024 | 50.76 | 47.99 | 50.85 | 46.30 | 1.342 times |
25 Fri Oct 2024 | 47.36 | 48.59 | 48.94 | 45.44 | 1.167 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Crispr Therapeutics (CRSP)
Date | Monthly Closing Price | Open | High | Low | Volume |
18 Mon Nov 2024 | 47.30 | 46.96 | 59.07 | 46.30 | 1.059 times |
31 Thu Oct 2024 | 46.39 | 47.00 | 50.50 | 44.44 | 1.167 times |
30 Mon Sep 2024 | 46.98 | 47.37 | 51.99 | 43.42 | 0.769 times |
30 Fri Aug 2024 | 47.72 | 57.39 | 57.68 | 44.80 | 0.967 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Crispr Therapeutics (CRSP)
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.28 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Crispr Therapeutics ( (CRSP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Crispr Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Crispr Therapeutics in short term but the sell signal is initial and weak.
Crispr Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Crispr Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Crispr Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 50.28 and Crispr Therapeutics (CRSP) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Crispr Therapeutics (CRSP) stock. Volume based technical analysis of Crispr Therapeutics (CRSP) stock is negative.
Crispr Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.